Treatment options following metformin in primary prevention populations with type 2 diabetes: which is the right road to take?

Taylor and Francis Group, Expert Review of Clinical Pharmacology, 10(14), p. 1189-1192, 2021

Journal article published in 2021 by Theocharis Koufakis

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by